Skip to main content
SpringerLink
Log in

Reasons for Nonadherence

  • Chapter
  • First Online:
Book cover Treatment Adherence in Dermatology

Part of the book series: Updates in Clinical Dermatology ((UCD))

Abstract

Patients’ failure to adhere to treatment regimens results in poor health outcomes and increased financial expenditure. Acknowledging common barriers to adherence can help providers anticipate how patients will incorporate treatment into their daily routine. Reasons for nonadherence may be patient-related, prescriber-related, and healthcare-related. Common reasons for nonadherence shared by the provider and patient include beliefs, perception of symptoms, cost, social support, education, forgetfulness, and psychiatric illnesses. Addressing common reasons for nonadherence can improve adherence and overall treatment outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304–14.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.

    Article  CAS  PubMed  Google Scholar 

  3. Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Feldman SR, Vrijens B, Gieler U, Piaserico S, Puig L, van de Kerkhof P. Treatment adherence intervention studies in dermatology and guidance on how to support adherence. Am J Clin Dermatol. 2017;18(2):253–71.

    Article  PubMed  Google Scholar 

  5. Nafradi L, Galimberti E, Nakamoto K, Schulz PJ. Intentional and unintentional medication non-adherence in hypertension: the role of health literacy, empowerment and medication beliefs. J Public Health Res. 2016;5(3):762.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Lehane E, McCarthy G. Intentional and unintentional medication non-adherence: a comprehensive framework for clinical research and practice? A discussion paper. Int J Nurs Stud. 2007;44(8):1468–77.

    Article  PubMed  Google Scholar 

  7. Sabate E. Adherence to long-term therapies. Evidence for action. Geneva: World Health Organization; 2003.

    Google Scholar 

  8. Horne R, Weinman J, Barber N, Elliot R, Morgan M. Adherence and compliance in medicine taking. Report for the National Coordinating Centre for NHS Service Delivery and Organization R and D (NCCSDO). 2005 [Available from: http://www.netscc.ac.uk/hsdr/files/project/SDO_FR_08-1412-076_V01.pdf.

  9. Arts DL, Voncken AG, Medlock S, Abu-Hanna A, van Weert HC. Reasons for intentional guideline non-adherence: a systematic review. Int J Med Inform. 2016;89:55–62.

    Article  PubMed  Google Scholar 

  10. DiMatteo MR, Haskard KB, Williams SL. Health beliefs, disease severity, and patient adherence: a meta-analysis. Med Care. 2007;45(6):521–8.

    Article  PubMed  Google Scholar 

  11. Devine F, Edwards T, Feldman SR. Barriers to treatment: describing them from a different perspective. Patient Prefer Adherence. 2018;12:129–33.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Kojima R, Fujiwara T, Matsuda A, Narita M, Matsubara O, Nonoyama S, et al. Factors associated with steroid phobia in caregivers of children with atopic dermatitis. Pediatr Dermatol. 2013;30(1):29–35.

    Article  PubMed  Google Scholar 

  13. Wade R, Paton F, Woolacott N. Systematic review of patient preference and adherence to the correct use of graduated compression stockings to prevent deep vein thrombosis in surgical patients. J Adv Nurs. 2017;73(2):336–48.

    Article  PubMed  Google Scholar 

  14. Patel NU, D'Ambra V, Feldman SR. Increasing adherence with topical agents for atopic dermatitis. Am J Clin Dermatol. 2017;18(3):323–32.

    Article  PubMed  Google Scholar 

  15. Ellis RM, Koch LH, McGuire E, Williams JV. Potential barriers to adherence in pediatric dermatology. Pediatr Dermatol. 2011;28(3):242–4.

    Article  PubMed  Google Scholar 

  16. Gokdemir G, Ari S, Koslu A. Adherence to treatment in patients with psoriasis vulgaris: Turkish experience. J Eur Acad Dermatol Venereol. 2008;22(3):330–5.

    Article  CAS  PubMed  Google Scholar 

  17. Lewis DJ, Feldman SR. Practical ways to improve patient adherence. Columbia, SC: CreateSpace Independent Publishing Platform. 2017.

    Google Scholar 

  18. Shubber Z, Mills EJ, Nachega JB, Vreeman R, Freitas M, Bock P, et al. Patient-reported barriers to adherence to antiretroviral therapy: a systematic review and meta-analysis. PLoS Med. 2016;13(11):e1002183.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Vitalis D. Factors affecting antiretroviral therapy adherence among HIV-positive pregnant and postpartum women: an adapted systematic review. Int J STD AIDS. 2013;24(6):427–32.

    Article  CAS  PubMed  Google Scholar 

  20. Storm A, Benfeldt E, Andersen SE, Andersen J. Basic drug information given by physicians is deficient, and patients' knowledge low. J Dermatolog Treat. 2009;20(4):190–3.

    Article  PubMed  Google Scholar 

  21. Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013;4:91.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Holtzman CW, Shea JA, Glanz K, Jacobs LM, Gross R, Hines J, et al. Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen’s Behavioral Model. AIDS Care. 2015;27(7):817–28.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Brundisini F, Vanstone M, Hulan D, DeJean D, Giacomini M. Type 2 diabetes patients’ and providers’ differing perspectives on medication nonadherence: a qualitative meta-synthesis. BMC Health Serv Res. 2015;15:516.

    Article  PubMed  PubMed Central  Google Scholar 

  24. O’Rourke G, O’Brien JJ. Identifying the barriers to antiepileptic drug adherence among adults with epilepsy. Seizure. 2017;45:160–8.

    Article  Google Scholar 

  25. Meiners M, Tavares NUL, Guimaraes LSP, Bertoldi AD, Pizzol T, Luiza VL, et al. Access and adherence to medication among people with diabetes in Brazil: evidences from PNAUM. Rev Bras Epidemiol. 2017;20(3):445–59.

    Article  PubMed  Google Scholar 

  26. Shirneshan E, Kyrychenko P, Matlin OS, Avila JP, Brennan TA, Shrank WH. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence. J Clin Pharm Ther. 2016;41(1):64–9.

    Article  CAS  PubMed  Google Scholar 

  27. Lee M, Salloum RG. Racial and ethnic disparities in cost-related medication non-adherence among cancer survivors. J Cancer Surviv. 2016;10(3):534–44.

    Article  PubMed  Google Scholar 

  28. Medication Adherence Tech: a dynamic and crowded market, but where are all the winners in the space? (Part 1 of 2) 2017. Available from: https://www.mobihealthnews.com/content/medication-adherence-tech-dynamic-and-crowded-market-where-are-winners-space-part-1-2.

  29. Shafer PO, Buchhalter J. Patient education: identifying risks and self-management approaches for adherence and sudden unexpected death in epilepsy. Neurol Clin. 2016;34(2):443–56.. ix

    Article  PubMed  Google Scholar 

  30. McKenzie K, Forsyth K, O'Hare A, McClure I, Rutherford M, Murray A, et al. The relationship between waiting times and ‘adherence’ to the Scottish Intercollegiate Guidelines Network 98 guideline in autism spectrum disorder diagnostic services in Scotland. Autism. 2016;20(4):395–401.

    Article  PubMed  Google Scholar 

  31. Sears C, Andersson Z, Cann M. Referral systems to integrate health and economic strengthening services for people with HIV: a qualitative assessment in Malawi. Glob Health Sci Pract. 2016;4(4):610–25.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Kehler DS, Kent D, Beaulac J, Strachan L, Wangasekara N, Chapman S, et al. Examining patient outcome quality indicators based on wait time from referral to entry into cardiac rehabilitation: a PILOT OBSERVATIONAL STUDY. J Cardiopulm Rehabil Prev. 2017;37(4):250–6.

    Article  PubMed  Google Scholar 

  33. Davies MJ, Gagliardino JJ, Gray LJ, Khunti K, Mohan V, Hughes R. Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review. Diabet Med. 2013;30(5):512–24.

    Article  CAS  PubMed  Google Scholar 

  34. Manne JM, Snively CS, Ramsey JM, Salgado MO, Barnighausen T, Reich MR. Barriers to treatment access for Chagas disease in Mexico. PLoS Negl Trop Dis. 2013;7(10):e2488.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Baker DW. The meaning and the measure of health literacy. J Gen Intern Med. 2006;21(8):878–83.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Wolf MS, Davis TC, Osborn CY, Skripkauskas S, Bennett CL, Makoul G. Literacy, self-efficacy, and HIV medication adherence. Patient Educ Couns. 2007;65(2):253–60.

    Article  PubMed  Google Scholar 

  37. In: Nielsen-Bohlman L, Panzer AM, Kindig DA, editors. Health literacy: a prescription to end confusion. Washington DC: 2004 by the National Academy of Sciences; 2004.

    Google Scholar 

  38. Kutner M, Greenberg E, Jin Y, Paulsen C. The health literacy of America’s adults: results from the 2003 National Assessment of Adult Literacy (NCES 2006-483). Washington, DC: U.S. Department of Education: National Center for Education Statistics; 2006.

    Google Scholar 

  39. Miller TA. Health literacy and adherence to medical treatment in chronic and acute illness: a meta-analysis. Patient Educ Couns. 2016;99(7):1079–86.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Brown MT, Bussell J, Dutta S, Davis K, Strong S, Mathew S. Medication adherence: truth and consequences. Am J Med Sci. 2016;351(4):387–99.

    Article  PubMed  Google Scholar 

  41. Hayward KL, Martin JH, Cottrell WN, Karmakar A, Horsfall LU, Patel PJ, et al. Patient-oriented education and medication management intervention for people with decompensated cirrhosis: study protocol for a randomized controlled trial. Trials. 2017;18(1):339.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Kobak KA, Taylor L, Katzelnick DJ, Olson N, Clagnaz P, Henk HJ. Antidepressant medication management and Health Plan Employer Data Information Set (HEDIS) criteria: reasons for nonadherence. J Clin Psychiatry. 2002;63(8):727–32.

    Article  PubMed  Google Scholar 

  43. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47(6):555–67.

    Article  CAS  PubMed  Google Scholar 

  44. Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS One. 2013;8(12):e80633.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Galvan FH, Bogart LM, Wagner GJ, Klein DJ, Chen YT. Conceptualisations of masculinity and self-reported medication adherence among HIV-positive Latino men in Los Angeles, California, USA. Cult Health Sex. 2014;16(6):697–709.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Devaux S, Castela A, Archier E, Gallini A, Joly P, Misery L, et al. Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2012;26(Suppl 3):61–7.

    Article  PubMed  Google Scholar 

  47. Winters A, Esse T, Bhansali A, Serna O, Mhatre S, Sansgiry S. Physician perception of patient medication adherence in a cohort of medicare advantage plans in Texas. J Manag Care Spec Pharm. 2016;22(3):305–12.

    PubMed  Google Scholar 

  48. Lapane KL, Dube CE, Schneider KL, Quilliam BJ. Misperceptions of patients vs providers regarding medication-related communication issues. Am J Manag Care. 2007;13(11):613–8.

    PubMed  Google Scholar 

  49. Linder LA, Wu YP, Macpherson CF, Fowler B, Wilson A, Jo Y, et al. Oral medication adherence among adolescents and young adults with cancer before and following use of a smartphone-based medication reminder app. J Adolesc Young Adult Oncol. 2018;8(2):122–30.

    Article  PubMed  Google Scholar 

  50. Butow P, Palmer S, Pai A, Goodenough B, Luckett T, King M. Review of adherence-related issues in adolescents and young adults with cancer. J Clin Oncol. 2010;28(32):4800–9.

    Article  PubMed  Google Scholar 

  51. Simons LE, McCormick ML, Mee LL, Blount RL. Parent and patient perspectives on barriers to medication adherence in adolescent transplant recipients. Pediatr Transplant. 2009;13(3):338–47.

    Article  PubMed  Google Scholar 

  52. Koster ES, Philbert D, de Vries TW, van Dijk L, Bouvy ML. “I just forget to take it”: asthma self-management needs and preferences in adolescents. J Asthma. 2015;52(8):831–7.

    Article  CAS  PubMed  Google Scholar 

  53. Muluneh B, Deal A, Alexander MD, Keisler MD, Markey JM, Neal JM, et al. Patient perspectives on the barriers associated with medication adherence to oral chemotherapy. J Oncol Pharm Pract. 2018;24(2):98–109.

    Article  PubMed  Google Scholar 

  54. Jones-Caballero M, Pedrosa E, Penas PF. Self-reported adherence to treatment and quality of life in mild to moderate acne. Dermatology. 2008;217(4):309–14.

    Article  PubMed  Google Scholar 

  55. Goren A, Carter C, Lee S. Patient reported health outcomes and non-adherence in psoriasis patients receiving adalimumab or ustekinumab for moderate to severe plaque psoriasis. J Dermatolog Treat. 2016;27(1):43–50.

    Article  CAS  PubMed  Google Scholar 

  56. Pena-Robichaux V, Kvedar JC, Watson AJ. Text messages as a reminder aid and educational tool in adults and adolescents with atopic dermatitis: a pilot study. Dermatol Res Pract. 2010;2010:1–6.

    Article  Google Scholar 

  57. Tarn DM, Flocke SA. New prescriptions: how well do patients remember important information? Fam Med. 2011;43(4):254–9.

    PubMed  PubMed Central  Google Scholar 

  58. Jansen J, Butow PN, van Weert JC, van Dulmen S, Devine RJ, Heeren TJ, et al. Does age really matter? Recall of information presented to newly referred patients with cancer. J Clin Oncol. 2008;26(33):5450–7.

    Article  PubMed  Google Scholar 

  59. Rork JF, Sheehan WJ, Gaffin JM, Timmons KG, Sidbury R, Schneider LC, et al. Parental response to written eczema action plans in children with eczema. Arch Dermatol. 2012;148(3):391–2.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Bloomberg J. Digital transformation moves pharma ‘Beyond the Pill’ 2014. Available from: https://www.forbes.com/sites/jasonbloomberg/2014/08/15/digital-transformation-moves-pharma-beyond-the-pill/#774a89ab1c58.

  61. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101–7.

    Article  CAS  PubMed  Google Scholar 

  62. Feldman SR, Zhao Y, Shi L, Tran MH. Economic and comorbidity burden among patients with moderate-to-severe psoriasis. J Manag Care Spec Pharm. 2015;21(10):874–88.

    PubMed  Google Scholar 

  63. Kulkarni AS, Balkrishnan R, Camacho FT, Anderson RT, Feldman SR. Medication and health care service utilization related to depressive symptoms in older adults with psoriasis. J Drugs Dermatol. 2004;3(6):661–6.

    PubMed  Google Scholar 

  64. Li Y, Zhou H, Cai B, Kahler KH, Tian H, Gabriel S, et al. Group-based trajectory modeling to assess adherence to biologics among patients with psoriasis. Clinicoecon Outcomes Res. 2014;6:197–208.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Miller IM, McAndrew RJ, Hamzavi I. Prevalence, risk factors, and comorbidities of hidradenitis suppurativa. Dermatol Clin. 2016;34(1):7–16.

    Article  CAS  PubMed  Google Scholar 

  66. Silverberg JI. Selected comorbidities of atopic dermatitis: atopy, neuropsychiatric, and musculoskeletal disorders. Clin Dermatol. 2017;35(4):360–6.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Holmes AD, Spoendlin J, Chien AL, Baldwin H, Chang ALS. Evidence-based update on rosacea comorbidities and their common physiologic pathways. J Am Acad Dermatol. 2018;78(1):156–66.

    Article  PubMed  Google Scholar 

  68. Patel N, Nadkarni A, Cardwell LA, Vera N, Frey C, Patel N, et al. Psoriasis, depression, and inflammatory overlap: a review. Am J Clin Dermatol. 2017;18(5):613–20.

    Article  PubMed  Google Scholar 

  69. Sin NL, DiMatteo MR. Depression treatment enhances adherence to antiretroviral therapy: a meta-analysis. Ann Behav Med. 2014;47(3):259–69.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Madden JM, Graves AJ, Ross-Degnan D, Briesacher BA, Soumerai SB. Cost-related medication nonadherence after implementation of Medicare Part D, 2006–2007. JAMA. 2009;302(16):1755–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Williams J, Steers WN, Ettner SL, Mangione CM, Duru OK. Cost-related nonadherence by medication type among Medicare Part D beneficiaries with diabetes. Med Care. 2013;51(2):193–8.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Blanchard J, Madden JM, Ross-Degnan D, Gresenz CR, Soumerai SB. The relationship between emergency department use and cost-related medication nonadherence among Medicare beneficiaries. Ann Emerg Med. 2013;62(5):475–85.

    Article  PubMed  Google Scholar 

  73. Harrold LR, Briesacher BA, Peterson D, Beard A, Madden J, Zhang F, et al. Cost-related medication nonadherence in older patients with rheumatoid arthritis. J Rheumatol. 2013;40(2):137–43.

    Article  PubMed  Google Scholar 

  74. Musich S, Cheng Y, Wang SS, Hommer CE, Hawkins K, Yeh CS. Pharmaceutical cost-saving strategies and their association with medication adherence in a Medicare Supplement Population. J Gen Intern Med. 2015;30(8):1208–14.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Zhang Y, Baik SH. Race/ethnicity, disability, and medication adherence among medicare beneficiaries with heart failure. J Gen Intern Med. 2014;29(4):602–7.

    Article  PubMed  Google Scholar 

  76. Balkrishnan R, Bhosle MJ, Camacho FT, Anderson RT. Predictors of medication adherence and associated health care costs in an older population with overactive bladder syndrome: a longitudinal cohort study. J Urol. 2006;175(3 Pt 1):1067–71; discussion 71–2.

    Article  PubMed  Google Scholar 

  77. Rolnick SJ, Pawloski PA, Hedblom BD, Asche SE, Bruzek RJ. Patient characteristics associated with medication adherence. Clin Med Res. 2013;11(2):54–65.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA. 2007;298(1):61–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Gibson TB, Ozminkowski RJ, Goetzel RZ. The effects of prescription drug cost sharing: a review of the evidence. Am J Manag Care. 2005;11(11):730–40.

    PubMed  Google Scholar 

  80. Austvoll-Dahlgren A, Aaserud M, Vist G, Ramsay C, Oxman AD, Sturm H, et al. Pharmaceutical policies: effects of cap and co-payment on rational drug use. Cochrane Database Syst Rev. 2008;1:CD007017.

    Google Scholar 

  81. Slota C, Davis SA, Blalock SJ, Carpenter DM, Muir KW, Robin AL, et al. Patient-physician communication on medication cost during Glaucoma visits. Optom Vis Sci. 2017;94(12):1095–101.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Lee IA, Maibach HI. Pharmionics in dermatology: a review of topical medication adherence. Am J Clin Dermatol. 2006;7(4):231–6.

    Article  PubMed  Google Scholar 

  83. Tan X, Feldman SR, Chang J, Balkrishnan R. Topical drug delivery systems in dermatology: a review of patient adherence issues. Expert Opin Drug Deliv. 2012;9(10):1263–71.

    Article  CAS  PubMed  Google Scholar 

  84. Shokeen D, O’Neill JL, Taheri A, Feldman SR. Are topical keratolytic agents needed in the treatment of scalp psoriasis? Dermatol Online J. 2014;20(3).

    Google Scholar 

  85. Feldman SR, Horn EJ, Balkrishnan R, Basra MK, Finlay AY, McCoy D, et al. Psoriasis: improving adherence to topical therapy. J Am Acad Dermatol. 2008;59(6):1009–16.

    Article  PubMed  Google Scholar 

Download references

Conflicts of Interest

Dr. Steven Feldman has received research, speaking and/or consulting support from a variety of companies including Galderma, GSK/Stiefel, Almirall, Leo Pharma, Boehringer Ingelheim, Mylan, Celgene, Pfizer, Valeant, Abbvie, Samsung, Janssen, Lilly, Menlo, Merck, Novartis, Regeneron, Sanofi, Novan, Qurient, National Biological Corporation, Caremark, Advance Medical, Sun Pharma, Suncare Research, Informa, UpToDate and National Psoriasis Foundation. He is founder and majority owner of www.DrScore.com and founder and part owner of Causa Research, a company dedicated to enhancing patients’ adherence to treatment.

Dr. Adrian Pona and Dr. Abigail Cline have no conflicts to disclose.

Author information

Authors and Affiliations

  1. Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA

    Adrian Pona & Abigail Cline

  2. Departments of Dermatology, Pathology and Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, USA

    Steven R. Feldman

Authors
  1. Adrian Pona
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abigail Cline
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Steven R. Feldman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adrian Pona .

Editor information

Editors and Affiliations

  1. Departments of Dermatology, Pathology and Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, USA

    Steven R. Feldman

  2. Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA

    Abigail Cline

  3. Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA

    Adrian Pona

  4. Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA

    Sree S. Kolli

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pona, A., Cline, A., Feldman, S.R. (2020). Reasons for Nonadherence. In: Feldman, S., Cline, A., Pona, A., Kolli, S. (eds) Treatment Adherence in Dermatology. Updates in Clinical Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-030-27809-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-27809-0_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-27808-3

  • Online ISBN: 978-3-030-27809-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation